Clinical Trial Update: Pelvic Nodes Ultra-Hypo vs Conventionally Fractionated IMRT With HDR Boost in Prostate Cancer. [NA]

View source ↗

Summary

The clinical trial NCT05820633 evaluating pelvic nodal ultra-hypofractionated IMRT with HDR boost versus conventional fractionated IMRT in prostate cancer has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Prostate Cancer, Node; Prostate | NA | Status: SUSPENDED